Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

V1RC2 Inhibitors

V1RC2 inhibitors represent a class of chemical compounds characterized by their specific interactions with the V1RC2 protein, defined by a variety of chemical structures and functional groups that facilitate their binding and inhibition. These compounds are typically synthesized through the incorporation of diverse functional groups, including heterocyclic rings, aromatic systems, and various substituents that enhance their binding affinity and selectivity. The core structures of V1RC2 inhibitors often feature a blend of hydrophobic and hydrophilic regions, which are meticulously designed to interact with the target protein's active or allosteric sites. The specificity of these interactions is governed by the precise arrangement of functional groups, which allows the inhibitors to form stable complexes with the protein.

The design and optimization of V1RC2 inhibitors involve sophisticated chemical and computational strategies. Synthesis begins with the construction of complex molecules through various organic reactions, followed by structural modifications to improve efficacy. Computational tools such as molecular docking and molecular dynamics simulations play a crucial role in predicting the binding modes of these inhibitors and guiding structural adjustments. Iterative cycles of synthesis and testing refine the chemical properties and binding interactions of the inhibitors. The development process emphasizes the importance of understanding the three-dimensional structure of the V1RC2 protein and the nature of its interaction with potential inhibitors, leading to the creation of compounds with high specificity and potency.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Acts as a phytoalexin, modulating cellular signaling pathways, potentially inhibiting Vomeronasal 1 receptor 29 expression.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Exhibits anti-inflammatory properties, interfering with molecular pathways involved in Vomeronasal 1 receptor 29 expression.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

A potent antioxidant, EGCG may disrupt pathways involved in Vomeronasal 1 receptor 29 expression, potentially inhibiting it.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Known for its anti-inflammatory effects, quercetin could interfere with the signaling cascades associated with Vomeronasal 1 receptor 29 expression.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Acts as a tyrosine kinase inhibitor, potentially disrupting cellular pathways involved in Vomeronasal 1 receptor 29 expression.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

A natural compound with anti-inflammatory properties, sulforaphane may modulate cellular pathways related to Vomeronasal 1 receptor 29 expression.

Luteolin

491-70-3sc-203119
sc-203119A
sc-203119B
sc-203119C
sc-203119D
5 mg
50 mg
500 mg
5 g
500 g
$27.00
$51.00
$101.00
$153.00
$1925.00
40
(1)

Exhibits anti-inflammatory effects and may interfere with signaling pathways associated with Vomeronasal 1 receptor 29 expression.

Baicalein

491-67-8sc-200494
sc-200494A
sc-200494B
sc-200494C
10 mg
100 mg
500 mg
1 g
$32.00
$42.00
$162.00
$292.00
12
(1)

Has been shown to modulate inflammatory responses, potentially impacting the expression of Vomeronasal 1 receptor 29.

Gingerol

23513-14-6sc-201519
sc-201519A
5 mg
20 mg
$109.00
$387.00
5
(1)

Exhibits anti-inflammatory properties and may interfere with cellular pathways involved in Vomeronasal 1 receptor 29 expression.

Diosgenin

512-04-9sc-205652
sc-205652B
sc-205652A
5 g
25 g
100 g
$47.00
$131.00
$517.00
4
(1)

Displays anti-inflammatory effects, potentially interfering with molecular pathways implicated in Vomeronasal 1 receptor 29 expression.